Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | PIK3CD | O00329 | 2/20 | 0.32 |
| ▸ | LMNA | P02545 | 2/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.32 |
| ▸ | EP300 | Q09472 | 1/20 | 0.31 |
| ▸ | MPO | P05164 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13692648 | 0.81 | SMN1; SMN2 (0.39) | GAAALDH1A1MAPTKDM4EMEN1 | |
| SCHEMBL14694502 | 0.80 | L3MBTL1 (0.35) | GAAALDH1A1MAPTMEN1THRB | |
| SCHEMBL2584448 | 0.78 | KDM4E (0.35) | GAAALDH1A1MAPTKDM4ETHRB | |
| SCHEMBL14159354 | 0.77 | MEN1 (0.41) | GAAALDH1A1MAPTKDM4EMEN1 | |
| SCHEMBL13931148 | 0.76 | HTT (0.39) | GAAALDH1A1MEN1KMT2ASMN1; SMN2 | |
| SCHEMBL3875987 | 0.76 | KDM4E (0.44) | GAAALDH1A1MAPTKDM4EMEN1 | |
| SCHEMBL10586756 | 0.75 | ALDH1A1 (0.33) | ALDH1A1KDM4EL3MBTL1 | |
| SCHEMBL10584563 | 0.73 | L3MBTL1 (0.32) | L3MBTL1 | |
| SCHEMBL14937879 | 0.73 | KMT2A (0.51) | GAAALDH1A1MAPTKDM4EMEN1 | |
| SCHEMBL2594812 | 0.73 | KMT2A (0.40) | GAAALDH1A1MAPTKDM4EMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2594558-A1 | COMPLEX COMPOUND AND OPTICAL RECORDING MEDIUM CONTAINING SAME | KH Neochem Co., Ltd. (JP) | 2013-05-22 | — | — | EP | disclosed |
| US-20130123494-A1 | COMPLEX COMPOUND AND OPTICAL RECORDING MEDIUM CONTAINING SAME | KH NEOCHEM CO., LTD. (JP) | 2013-05-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130123494-A1 | COMPLEX COMPOUND AND OPTICAL RECORDING MEDIUM CONTAINING SAME | TRPA1, KCNH3, HCN3 | GAA 4386/4885ALDH1A1 1467/4885MAPT 2222/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.